3D Global Biotech Inc. (TPEX:6808)
Taiwan
· Delayed Price · Currency is TWD 34.60
-1.30 (-3.62%)
Apr 29, 2026, 1:25 PM CST
3D Global Biotech Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Revenue | 206.74 | 265.69 | 20.63 | 13.64 | 11.08 | Upgrade
|
| Revenue Growth (YoY) | -22.19% | 1187.67% | 51.23% | 23.19% | -16.48% | Upgrade
|
| Cost of Revenue | 58.33 | 91.18 | 15.36 | 10.93 | 9.27 | Upgrade
|
| Gross Profit | 148.41 | 174.51 | 5.27 | 2.72 | 1.8 | Upgrade
|
| Selling, General & Admin | 56.38 | 42.54 | 29.53 | 29.53 | 26.41 | Upgrade
|
| Research & Development | 47.81 | 43.27 | 38.6 | 39.48 | 37.6 | Upgrade
|
| Operating Expenses | 106.96 | 86.02 | 68.13 | 69 | 64.01 | Upgrade
|
| Operating Income | 41.45 | 88.49 | -62.85 | -66.29 | -62.21 | Upgrade
|
| Interest Expense | -1.4 | -0.12 | -0.18 | -0.26 | -0.26 | Upgrade
|
| Interest & Investment Income | 13 | 6.19 | 2.24 | 1.68 | 1.35 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.58 | 1.3 | 0.02 | -0.01 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.79 | 0.14 | 1.85 | 0.62 | 0.15 | Upgrade
|
| EBT Excluding Unusual Items | 51.69 | 96 | -58.92 | -64.25 | -60.97 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0 | - | - | - | Upgrade
|
| Asset Writedown | - | - | - | -18.89 | - | Upgrade
|
| Other Unusual Items | 0.62 | 0.07 | - | 0.01 | - | Upgrade
|
| Pretax Income | 52.31 | 96.07 | -58.92 | -83.13 | -60.97 | Upgrade
|
| Income Tax Expense | -14.22 | 4.37 | -0.96 | -16.05 | -1.26 | Upgrade
|
| Net Income | 66.53 | 91.7 | -57.95 | -67.09 | -59.71 | Upgrade
|
| Net Income to Common | 66.53 | 91.7 | -57.95 | -67.09 | -59.71 | Upgrade
|
| Net Income Growth | -27.45% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 78 | 69 | 56 | 55 | 54 | Upgrade
|
| Shares Outstanding (Diluted) | 79 | 71 | 56 | 55 | 54 | Upgrade
|
| Shares Change (YoY) | 11.92% | 26.08% | 2.32% | 1.69% | 0.77% | Upgrade
|
| EPS (Basic) | 0.86 | 1.33 | -1.03 | -1.22 | -1.11 | Upgrade
|
| EPS (Diluted) | 0.84 | 1.30 | -1.03 | -1.22 | -1.11 | Upgrade
|
| EPS Growth | -35.38% | - | - | - | - | Upgrade
|
| Free Cash Flow | 104.74 | 14.91 | -32.39 | -35.33 | -38.85 | Upgrade
|
| Free Cash Flow Per Share | 1.32 | 0.21 | -0.58 | -0.64 | -0.72 | Upgrade
|
| Dividend Per Share | 0.100 | 0.530 | - | - | - | Upgrade
|
| Dividend Growth | -81.13% | - | - | - | - | Upgrade
|
| Gross Margin | 71.79% | 65.68% | 25.56% | 19.91% | 16.28% | Upgrade
|
| Operating Margin | 20.05% | 33.31% | -304.62% | -485.87% | -561.71% | Upgrade
|
| Profit Margin | 32.18% | 34.52% | -280.87% | -491.73% | -539.10% | Upgrade
|
| Free Cash Flow Margin | 50.67% | 5.61% | -156.99% | -258.98% | -350.81% | Upgrade
|
| EBITDA | 58.16 | 104.62 | -46.49 | -47.15 | -42.46 | Upgrade
|
| EBITDA Margin | 28.13% | 39.38% | -225.30% | - | - | Upgrade
|
| D&A For EBITDA | 16.71 | 16.13 | 16.37 | 19.14 | 19.75 | Upgrade
|
| EBIT | 41.45 | 88.49 | -62.85 | -66.29 | -62.21 | Upgrade
|
| EBIT Margin | 20.05% | 33.31% | - | - | - | Upgrade
|
| Effective Tax Rate | - | 4.55% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.